1. Home
  2. FRPT vs STOK Comparison

FRPT vs STOK Comparison

Compare FRPT & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshpet Inc.

FRPT

Freshpet Inc.

HOLD

Current Price

$50.00

Market Cap

2.4B

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.46

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRPT
STOK
Founded
2004
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
FRPT
STOK
Price
$50.00
$29.46
Analyst Decision
Buy
Strong Buy
Analyst Count
17
10
Target Price
$76.94
$39.20
AVG Volume (30 Days)
1.9M
475.5K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
183.87
92.73
EPS
0.91
N/A
Revenue
$1,102,015,000.00
$184,420,000.00
Revenue This Year
$11.34
N/A
Revenue Next Year
$9.13
$77.49
P/E Ratio
$54.79
N/A
Revenue Growth
13.01
404.50
52 Week Low
$46.45
$10.64
52 Week High
$86.00
$40.22

Technical Indicators

Market Signals
Indicator
FRPT
STOK
Relative Strength Index (RSI) 38.78 37.50
Support Level $47.59 $28.02
Resistance Level $56.73 $35.11
Average True Range (ATR) 2.26 1.35
MACD 0.52 -0.06
Stochastic Oscillator 51.82 23.56

Price Performance

Historical Comparison
FRPT
STOK

About FRPT Freshpet Inc.

Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: